Monte Rosa Therapeutics (GLUE) Current Leases (2023 - 2025)
Historic Current Leases for Monte Rosa Therapeutics (GLUE) over the last 3 years, with Q3 2025 value amounting to $4.2 million.
- Monte Rosa Therapeutics' Current Leases rose 1631.93% to $4.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.2 million, marking a year-over-year increase of 1631.93%. This contributed to the annual value of $3.7 million for FY2024, which is 1745.73% up from last year.
- Monte Rosa Therapeutics' Current Leases amounted to $4.2 million in Q3 2025, which was up 1631.93% from $4.1 million recorded in Q2 2025.
- In the past 5 years, Monte Rosa Therapeutics' Current Leases ranged from a high of $4.2 million in Q3 2025 and a low of $2.7 million during Q2 2023
- In the last 3 years, Monte Rosa Therapeutics' Current Leases had a median value of $3.5 million in 2024 and averaged $3.5 million.
- Per our database at Business Quant, Monte Rosa Therapeutics' Current Leases soared by 3014.62% in 2024 and then soared by 1554.56% in 2025.
- Quarter analysis of 3 years shows Monte Rosa Therapeutics' Current Leases stood at $3.2 million in 2023, then grew by 17.46% to $3.7 million in 2024, then grew by 14.19% to $4.2 million in 2025.
- Its Current Leases stands at $4.2 million for Q3 2025, versus $4.1 million for Q2 2025 and $3.9 million for Q1 2025.